<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>06926802604373</udiDi>
    <basicUdiDi>69268026MD72A00001U9</basicUdiDi>
    <tradeName>06926802604373</tradeName>
    <deviceName></deviceName>
    <manufacturerName>MEDCAPTAIN MEDICAL TECHNOLOGY CO., LTD.</manufacturerName>
    <manufacturerSrn>CN-MF-000005925</manufacturerSrn>
    <authorisedRepresentativeName>R Sight B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000010445</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W01030609</emdnCode>
    <emdnDescription>INTERLEUKIN 6 (IL-6)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MCL03402E</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-02T02:34:10.454Z</lastUpdated>
  </row>
  <row>
    <udiDi>04050598012462</udiDi>
    <basicUdiDi>4050598IAInflamM5</basicUdiDi>
    <tradeName>IDK® TNFα ELISA</tradeName>
    <deviceName>IDK® TNFα ELISA</deviceName>
    <manufacturerName>Immundiagnostik AG</manufacturerName>
    <manufacturerSrn>DE-MF-000020905</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030603</emdnCode>
    <emdnDescription>TUMOUR NECROSIS FACTORS (TNFα,TNFβ, ...)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Y9610</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T16:16:23.517Z</lastUpdated>
  </row>
  <row>
    <udiDi>04049325033320</udiDi>
    <basicUdiDi>4049325IVR05060003BS8</basicUdiDi>
    <tradeName>sInterleukin-2-Receptor ELISA</tradeName>
    <deviceName>sInterleukin-2-Receptor ELISA</deviceName>
    <manufacturerName>IBL International GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000015709</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030607</emdnCode>
    <emdnDescription>INTERLEUKINS RECEPTORS (IL-2R,IL6R ...)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>30201813</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T16:04:58.655Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976485022742</udiDi>
    <basicUdiDi>697648502IL6UE</basicUdiDi>
    <tradeName>Pylon Interleukin-6</tradeName>
    <deviceName>Pylon Interleukin-6</deviceName>
    <manufacturerName>ET Healthcare (Suzhou) Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000039448</manufacturerSrn>
    <authorisedRepresentativeName>RIOMAVIX SOCIEDAD LIMITADA</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000001202</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030609</emdnCode>
    <emdnDescription>INTERLEUKIN 6 (IL-6)</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>30-2077	200 tests/kit</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-30T09:19:28.669Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976485022735</udiDi>
    <basicUdiDi>697648502IL6UE</basicUdiDi>
    <tradeName>Pylon Interleukin-6</tradeName>
    <deviceName>Pylon Interleukin-6</deviceName>
    <manufacturerName>ET Healthcare (Suzhou) Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000039448</manufacturerSrn>
    <authorisedRepresentativeName>RIOMAVIX SOCIEDAD LIMITADA</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000001202</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030609</emdnCode>
    <emdnDescription>INTERLEUKIN 6 (IL-6)</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>20-2077	100 tests/kit</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-30T09:19:22.647Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976485022728</udiDi>
    <basicUdiDi>697648502IL6UE</basicUdiDi>
    <tradeName>Pylon Interleukin-6</tradeName>
    <deviceName>Pylon Interleukin-6</deviceName>
    <manufacturerName>ET Healthcare (Suzhou) Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000039448</manufacturerSrn>
    <authorisedRepresentativeName>RIOMAVIX SOCIEDAD LIMITADA</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000001202</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030609</emdnCode>
    <emdnDescription>INTERLEUKIN 6 (IL-6)</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>10-2077	40 tests/kit</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-30T09:19:21.460Z</lastUpdated>
  </row>
  <row>
    <udiDi>06975577177490</udiDi>
    <basicUdiDi>697015090000044H4</basicUdiDi>
    <tradeName>AutoLumo IL-6 Calibrators</tradeName>
    <deviceName>IL-6 CLIA Micrparticles</deviceName>
    <manufacturerName>Autobio Diagnostics Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000003348</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030608</emdnCode>
    <emdnDescription>CYTOKINES CALIBRATORS/CONTROLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CA100401</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T09:16:39.350Z</lastUpdated>
  </row>
  <row>
    <udiDi>06971390439982</udiDi>
    <basicUdiDi>69713904310027D</basicUdiDi>
    <tradeName>HOKAPI™ IL-6</tradeName>
    <deviceName>HOKAPI™ IL-6</deviceName>
    <manufacturerName>Suzhou Hokapi Biomedical Engineering Co., Ltd..</manufacturerName>
    <manufacturerSrn>CN-MF-000013723</manufacturerSrn>
    <authorisedRepresentativeName>Shanghai International Holding Corp. GmbH(Europe)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000001</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030609</emdnCode>
    <emdnDescription>INTERLEUKIN 6 (IL-6)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>011002101</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-30T09:02:38.765Z</lastUpdated>
  </row>
  <row>
    <udiDi>06970522648339</udiDi>
    <basicUdiDi>B-06970522648339</basicUdiDi>
    <tradeName>Interleukin-1β (IL-1β) Assay Kit (Chemiluminescent Immunoassay)</tradeName>
    <deviceName>Interleukin-1β (IL-1β) Assay Kit (Chemiluminescent Immunoassay)</deviceName>
    <manufacturerName>Sichuan Orienter Biotechnology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000003026</manufacturerSrn>
    <authorisedRepresentativeName>Medunion S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000019366</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030606</emdnCode>
    <emdnDescription>OTHER INTERLEUKINS (EXCEPT FOR IL-6)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DC0801</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T01:47:25.312Z</lastUpdated>
  </row>
  <row>
    <udiDi>06970522642290</udiDi>
    <basicUdiDi>B-06970522642290</basicUdiDi>
    <tradeName>Alpha Tumor Necrosis Factor (TNFα) Assay Kit (Chemiluminescent Immunoassay)</tradeName>
    <deviceName>Alpha Tumor Necrosis Factor (TNFα) Assay Kit (Chemiluminescent Immunoassay)</deviceName>
    <manufacturerName>Sichuan Orienter Biotechnology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000003026</manufacturerSrn>
    <authorisedRepresentativeName>Medunion S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000019366</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030603</emdnCode>
    <emdnDescription>TUMOUR NECROSIS FACTORS (TNFα,TNFβ, ...)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DC0601</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T01:46:01.236Z</lastUpdated>
  </row>
  <row>
    <udiDi>06970522641699</udiDi>
    <basicUdiDi>B-06970522641699</basicUdiDi>
    <tradeName>Interleukin -10 (IL-10) Assay Kit (Chemiluminescent Immunoassay)</tradeName>
    <deviceName>Interleukin -10 (IL-10) Assay Kit (Chemiluminescent Immunoassay)</deviceName>
    <manufacturerName>Sichuan Orienter Biotechnology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000003026</manufacturerSrn>
    <authorisedRepresentativeName>Medunion S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000019366</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030606</emdnCode>
    <emdnDescription>OTHER INTERLEUKINS (EXCEPT FOR IL-6)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DC0701</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T01:45:51.636Z</lastUpdated>
  </row>
  <row>
    <udiDi>06970522641392</udiDi>
    <basicUdiDi>B-06970522641392</basicUdiDi>
    <tradeName>Interleukin -8 (IL-8) Assay Kit (Chemiluminescent Immunoassay)</tradeName>
    <deviceName>Interleukin -8 (IL-8) Assay Kit (Chemiluminescent Immunoassay)</deviceName>
    <manufacturerName>Sichuan Orienter Biotechnology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000003026</manufacturerSrn>
    <authorisedRepresentativeName>Medunion S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000019366</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030606</emdnCode>
    <emdnDescription>OTHER INTERLEUKINS (EXCEPT FOR IL-6)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DC1001</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T01:45:45.628Z</lastUpdated>
  </row>
  <row>
    <udiDi>06970522641095</udiDi>
    <basicUdiDi>B-06970522641095</basicUdiDi>
    <tradeName>Interleukin-2 Receptor (IL-2R) Assay Kit (Chemiluminescent Immunoassay)</tradeName>
    <deviceName>Interleukin-2 Receptor (IL-2R) Assay Kit (Chemiluminescent Immunoassay)</deviceName>
    <manufacturerName>Sichuan Orienter Biotechnology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000003026</manufacturerSrn>
    <authorisedRepresentativeName>Medunion S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000019366</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030607</emdnCode>
    <emdnDescription>INTERLEUKINS RECEPTORS (IL-2R,IL6R ...)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DC0901</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T01:45:42.024Z</lastUpdated>
  </row>
  <row>
    <udiDi>06970150906559</udiDi>
    <basicUdiDi>697015090000044H4</basicUdiDi>
    <tradeName>IL-6 CLIA Microparticles</tradeName>
    <deviceName>IL-6 CLIA Micrparticles</deviceName>
    <manufacturerName>Autobio Diagnostics Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000003348</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030609</emdnCode>
    <emdnDescription>INTERLEUKIN 6 (IL-6)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CMH0501</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-29T19:46:11.094Z</lastUpdated>
  </row>
  <row>
    <udiDi>06954414798999</udiDi>
    <basicUdiDi>B-06954414798999</basicUdiDi>
    <tradeName>MAGICL IL-8 (CLIA)</tradeName>
    <deviceName>MAGICL IL-8 (CLIA)</deviceName>
    <manufacturerName>Getein Biotech, Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000017986</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030606</emdnCode>
    <emdnDescription>OTHER INTERLEUKINS (EXCEPT FOR IL-6)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>/</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-06-28T15:36:23.746Z</lastUpdated>
  </row>
  <row>
    <udiDi>06954414798982</udiDi>
    <basicUdiDi>B-06954414798982</basicUdiDi>
    <tradeName>MAGICL TNF-α (CLIA)</tradeName>
    <deviceName>MAGICL TNF-α (CLIA)</deviceName>
    <manufacturerName>Getein Biotech, Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000017986</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030603</emdnCode>
    <emdnDescription>TUMOUR NECROSIS FACTORS (TNFα,TNFβ, ...)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>/</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-06-28T15:36:22.539Z</lastUpdated>
  </row>
  <row>
    <udiDi>06954414798975</udiDi>
    <basicUdiDi>B-06954414798975</basicUdiDi>
    <tradeName>MAGICL IL-10 (CLIA)</tradeName>
    <deviceName>MAGICL IL-10 (CLIA)</deviceName>
    <manufacturerName>Getein Biotech, Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000017986</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030606</emdnCode>
    <emdnDescription>OTHER INTERLEUKINS (EXCEPT FOR IL-6)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>/</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-06-28T15:36:16.543Z</lastUpdated>
  </row>
  <row>
    <udiDi>06954414798968</udiDi>
    <basicUdiDi>B-06954414798968</basicUdiDi>
    <tradeName>MAGICL IL-1β (CLIA)</tradeName>
    <deviceName>MAGICL IL-1β (CLIA)</deviceName>
    <manufacturerName>Getein Biotech, Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000017986</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030606</emdnCode>
    <emdnDescription>OTHER INTERLEUKINS (EXCEPT FOR IL-6)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>/</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-06-28T15:36:15.333Z</lastUpdated>
  </row>
  <row>
    <udiDi>06954414798951</udiDi>
    <basicUdiDi>B-06954414798951</basicUdiDi>
    <tradeName>MAGICL IL-2R (CLIA)</tradeName>
    <deviceName>MAGICL IL-2R (CLIA)</deviceName>
    <manufacturerName>Getein Biotech, Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000017986</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030607</emdnCode>
    <emdnDescription>INTERLEUKINS RECEPTORS (IL-2R,IL6R ...)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>/</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-06-28T15:36:14.131Z</lastUpdated>
  </row>
  <row>
    <udiDi>06954414798388</udiDi>
    <basicUdiDi>B-06954414798388</basicUdiDi>
    <tradeName>MAGICL IL-6 (CLIA)</tradeName>
    <deviceName>MAGICL IL-6 (CLIA)</deviceName>
    <manufacturerName>Getein Biotech, Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000017986</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030609</emdnCode>
    <emdnDescription>INTERLEUKIN 6 (IL-6)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>/</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-06-28T15:33:15.675Z</lastUpdated>
  </row>
</eudamedExport>